Israel seen as well-positioned to enter and disrupt medical cannabis minister Uri Ariel is quoted as saying “the Israeli research conditions for. Cannabis in Israel is illegal but allowed for some specified medical usages. Citizens caught Research and innovation in the area is supported by the Ministry of Health and currently being dedicated 8 million Israel's liberal stance on cannabis stands in contrast to the rest of the Middle East region where in some countries. Health Minister Yaakov Litzman: "The attitude towards cannabis should be similar to any Due to the international interest in medical cannabis from Israel due to its professional quality and in view of the inherent economic.
Israeli on The Ministry cannabis Health’s standpoint of medical
You can speak to an American who understands your concerns and will walk you through the entire process, from dealing with insurance to making appointments, and even getting someone to escort your. It sounds like my dad has decided to hire you and I'm thrilled. He actually seems much calmer than he has been in a long time and he is very happy with what the EMA Care staff has done so far.
You provide an amazing service and I feel very fortunate to have you on board. My child had a range of medical needs while abroad, some anticipated and others not, and she was there for him and me — even in the middle of the night, -- always calm, reassuring, thinking out of the box, getting him to the appropriate medical professionals.
Thank you and may Hashem bless you for the work you do. My son Jacob said your allergy card has been very helpful. I am so grateful- beyond words. Thank you for delivering our allergy free baked goods to our hotel. We just tasted the focaccia and it was delicious. Schedule Your Free Consultation. Eliana Aaron Discusses Food Allergies. Back VIP Medical care. Monday, 27 February Sensitive and timely help I would like to recommend Eliana EMA care for her sensitive and timely help for clients who are having difficulty navigating the health care system Israel, specifically for Anglos, whether new olim or those of us who been here for many years.
Meticulous in their preparations During our recent visit to Israel, we really struggled to find food for our son who has anaphylactic level allergies to egg and sesame. Eliana on-line, we contacted her in the Comfortable, calm, and at ease We want to thank you from the bottom of our hearts for the amazing gift you have given us over this Pesach- the gift of having you with us!!!!
You made sure that they were so well looked after and they felt so at ease and Knowledgeable, thorough, and caring When our son was injured in a car accident during his yeshiva year in Israel, he had to start navigating the medical system on his own. Aaron accompanied our son in the ER and made sure he and we knew at every step exactly what was done and what needed to be done, especially important for someone who suffered a concussion and Truly amazing My son went to Israel for a year requiring infusion every weeks.
You can speak to an American who understands your concerns and will walk you through the entire process, from dealing with insurance to making appointments, and even getting someone to escort your My Father is so Happy It sounds like my dad has decided to hire you and I'm thrilled. My child had a range of medical needs while abroad, some anticipated and others not, and she was there for him and me — even in the middle of the night, -- always calm, reassuring, thinking out of the box, getting him to the appropriate medical professionals Very Helpful Thank you and may Hashem bless you for the work you do.
Delicious and Safe Thank you for delivering our allergy free baked goods to our hotel. We are very angry about how the process came about. Bar-On added that with an average three-month time period from harvesting through drying and processing to packaging, there were ways to address problems on the farm without closing the dispensaries and leaving patients without access to their medicine.
There is a total and utter lack of consideration of patients. The Health Ministry declined to comment as to why it closed both the farm and the dispensary without creating a backup plan for patients. Weisberg said the company is facing unprecedented growth, and is in the process of moving to a larger facility in order to be able to grow and process more marijuana. In an effort to speed the production process, the company decided to dry some of the cannabis outside rather than in greenhouses, Weisberg said.
Weisberg said the company signed a contract to have all of the cannabis radiated by an outside company to make sure nothing could harm patients from mold on cannabis dried outdoors. Tikun Olam is hopeful the ministry will finish its tests in the next few days and allow production and distribution to resume as normal. Soon, cannabis is expected to be approved for autism and fibromyalgia.
The Health Ministry receives applications per day for medical marijuana use, and there is a huge backlog for approvals. Tikun Olam is not currently accepting new patients because its current production is at its maximum, said Weisberg.
There are currently eight licensed marijuana-growing companies in Israel for local medical marijuana consumption. Tikun Olam is the largest. Questions were formulated as multiple-choice questions. The survey consisted of 18 questions relating to three major areas of interest:. For all questions but two Item numbers 1 and 2 in Section 2 , we calculated the percentage of detectors that selected a certain answer out of the total pool of responders. We used the chi-square or independent samples t -test to examine our hypotheses.
A The number of new cannabis permit requests issued per year; B perceived treatment efficacy; C observed treatment safety; D do you feel that you received adequate education on MC during your fellowship training?
A Most suitable indications; B contraindications; C rates of addiction. However, the majority A Is cannabis more or less hazardous to patients than opiates? B Which should be attempted first in pain patients? C Personal preference if you were patient yourself.
Responders present divided views on the need for a specialized government agency that reviews and issues cannabis permits following the recommendation of a specialist: B Does a valid professional framework underlie the MCU decisions?
C Legalization recreational use. Interestingly, an informative approach was to divide responders based on whether they would personally prefer to be treated with cannabis rather than opiates. Responses divided according to personal preference cannabis or opiates in case of personal need. A Number of new cannabis permits applied for per year. B Which should be attempted first? C Are you in favor of legalization? E Rates of addiction.
Error bars show standard error. There is an obvious need to explore the potential role of cannabis as a part of the armamentarium for chronic pain management. Unfortunately, scientific evidence still lags far behind the growing use driven by public approval. To date, this is the first survey examining attitudes toward the medical use of cannabis among a cohort of experienced pain specialists who actually use cannabis in their daily practice.
Of note, this survey has had impressive response rates — 50 out of 79 board-certified, active pain specialists have provided their inputs. The first emerging fact from this survey is that a majority of Israeli pain specialists are actively involved in the process leading to the use of cannabis by their patients.
Similarly, a majority finds MC to be moderately to highly effective. This, by itself, is a significant finding, especially when considering the fact that patients treated with MC are, by definition, refractory to most existing therapeutic avenues. Moreover, it is generally agreed that the side effect profile is relatively favorable, with most pain specialists encountering only mild adverse effects in most patients and rare serious side effects.
Expanding evidence indicates that herbal cannabis has analgesic effects in both neuropathic and nonneuropathic pain. Accordingly, these are indeed three of the better-described indications in literature. The most robust evidence exists for neuropathic pain, and there are several high-quality randomized controlled clinical trials establishing the analgesic efficacy of smoked cannabis. Notably, all these leading indications are conditions that are amenable to objective diagnosis.
This may reflect the helplessness that many pain specialists feel when dealing with these two patient populations, given the limited available effective treatment options for them.
Interestingly, low back pain and chronic postoperative pain, among the most common types of chronic pain syndromes seen in primary care and in pain clinics, were not considered to be good indications for MC treatment. This may reflect the basic distinction many physicians make between neuropathic and nociceptive pain syndromes with these two conditions usually ascribed to the last, although this, of course, is not always the case. It may also stem from the fact that both conditions have many treatment options, a large body of literature to support current treatments, as well as updated and useful clinical guidelines.
Most pain specialists view psychiatric morbidity, breastfeeding, and a young age as the leading contraindications. All these have indeed been implicated as potential contraindications, 30 — 32 although there is still no clear consensus as to their scope and validity, as well as to the factors contributing to individual patient vulnerability to neuropsychiatric adverse effects.
This is surprising and may be due to gaps in knowledge rather than a well-informed stance. The exact scope of addiction with cannabis is still largely debated. The question of the addictive potential of cannabis across different life stages and psychosocial contexts therefore remains largely unresolved.
Such misconceptions regarding contraindications and addiction rates reflect a clear gap in knowledge. It may be seen as somewhat worrying that pain specialists are comfortable prescribing what they consider themselves untrained to use. This may reflect the fact that they are being pressured to use cannabis by public opinion rather than by medicinal considerations.
Otherwise, it may reflect the difficulty in managing intractable pain patients, where often one turns to less-proven therapies and interventions in the face of ongoing suffering and dwindling options. Lastly, it may signify that pain specialists are not well trained in the use of cannabis but become aware and experienced during their posttraining medical practice. In any case, there is obviously a clear need for improvement in formal education on MC, since physicians practically use it in their clinics.
The comparison between MC and opiate therapy is intriguing for obvious reasons. Most also feel that cannabis is moderately to highly effective and this relates mostly to patients who have already failed opiate therapy, as this is a preliminary requirement for MC approval. This apparent discrepancy may stem from lingering biases but may also reflect the fact that doctors are more comfortable prescribing medications they have extensive literature on and that are properly manufactured, rather than using an unstandardized herbal product that is relatively unsupported, despite their own good experience with it.
Lastly, this may represent a feeling that opiates are nevertheless more powerful analgesics than cannabis and therefore more efficacious. In regards to legal and procedural issues concerning cannabis treatment, a small majority of responders feel that currently, there is a need for a specialized government agency for reviewing and handling cannabis permits.
However, a large majority feels that, currently, this agency does not operate under any clear criteria or sound scientific knowledge. Lastly, a majority of Israeli pain specialists personally support the legalization of cannabis, provided there is an age restriction.
This is extremely interesting since, as far as we know, this is the first survey of medical professionals reported thus far that shows such support. This may stem from the fact that these are pain specialists with actual experience with prescribing cannabis to a variety of patients under different conditions, who have had the chance to assess its overall and lasting effects, and have found them to be less daunting than assumed.
Otherwise, it may also reflect the view that legalization may solve many problems and dilemmas that accompany medicalization, which in turn is often seen as a step toward cannabis legalization in the long run. Interestingly, the question that was found to be most predictive of other favorable views on MC was whether the doctors preferred cannabis to opiates for themselves or a close family member in case of need.
These doctors also prescribed more cannabis to their patients and thought it should be attempted prior to opiates.
Thousands of patients in limbo as ministry temporarily shuts top cannabis grower
Breath of Life's huge new facility, the largest medical cannabis “We call it the ' Green Book,'” quipped Yuval Landschaft, director of the Medical Cannabis Unit in the Israeli Ministry of Health. View all stories by Brian Blum. Medical cannabis halted growth of Yehudah Haber's malignant brain tumor, but the Health Ministry, against advice of 4 doctors, has reduced his dosage by 60%. Tikun Olam Ltd. is the largest supplier of medical Cannabis in Israel, operating under license from the Israel Ministry of Health since